[{"address1": "7 Times Square", "address2": "Suite 2503", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 994385, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 620894, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior VP & Chief Development Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 659364, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.62, "open": 1.62, "dayLow": 1.54, "dayHigh": 1.6268, "regularMarketPreviousClose": 1.62, "regularMarketOpen": 1.62, "regularMarketDayLow": 1.54, "regularMarketDayHigh": 1.6268, "payoutRatio": 0.0, "beta": 2.504, "forwardPE": -3.6976745, "volume": 3465757, "regularMarketVolume": 3465757, "averageVolume": 3178123, "averageVolume10days": 3990030, "averageDailyVolume10Day": 3990030, "bid": 1.56, "ask": 1.6, "bidSize": 36, "askSize": 36, "marketCap": 234433168, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 2.48, "allTimeHigh": 718500.0, "allTimeLow": 0.5, "fiftyDayAverage": 1.8306, "twoHundredDayAverage": 1.59635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 142862976, "profitMargins": 0.0, "floatShares": 105039490, "sharesOutstanding": 147442239, "sharesShort": 25093376, "sharesShortPriorMonth": 20889586, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.2008, "heldPercentInsiders": 0.00317, "heldPercentInstitutions": 0.26487, "shortRatio": 8.45, "shortPercentOfFloat": 0.2025, "impliedSharesOutstanding": 147442239, "bookValue": 0.261, "priceToBook": 6.0919538, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -26259000, "trailingEps": -0.3, "forwardEps": -0.43, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": 0.27199996, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 1.59, "targetHighPrice": 7.5, "targetLowPrice": 6.0, "targetMeanPrice": 6.83333, "targetMedianPrice": 7.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 25297000, "totalCashPerShare": 0.24, "totalDebt": 737000, "quickRatio": 4.217, "currentRatio": 4.909, "debtToEquity": 2.818, "returnOnAssets": -0.68749, "returnOnEquity": -1.8071, "freeCashflow": -21631876, "operatingCashflow": -31359000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 1.2578604, "postMarketPrice": 1.61, "postMarketChange": 0.01999998, "regularMarketChange": -0.03, "regularMarketDayRange": "1.54 - 1.6268", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3178123, "fiftyTwoWeekLowChange": 0.82000005, "fiftyTwoWeekLowChangePercent": 1.0649352, "fiftyTwoWeekRange": "0.77 - 2.48", "fiftyTwoWeekHighChange": -0.89, "fiftyTwoWeekHighChangePercent": -0.35887095, "fiftyTwoWeekChangePercent": 27.199995, "regularMarketChangePercent": -1.85185, "dividendDate": 1573171200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.3, "epsForward": -0.43, "epsCurrentYear": -0.29333, "priceEpsCurrentYear": -5.420516, "fiftyDayAverageChange": -0.24059999, "fiftyDayAverageChangePercent": -0.13143231, "twoHundredDayAverageChange": -0.006349921, "twoHundredDayAverageChangePercent": -0.003977775, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "marketState": "CLOSED", "regularMarketPrice": 1.59, "corporateActions": [], "postMarketTime": 1762563595, "regularMarketTime": 1762549200, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]